Clinical Trials
UCLA faculty and Providers
Karim Chamie, MD
Associate Professor of Urology and Society of Urologic Oncology Fellowship Director. He attended Medical School at USC and completed Urological training at UC Davis. Dr. Chamie then completed a SUO certified fellowship in Urologic Oncology at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on bladder cancer and robotic surgery.
Leonard S. Marks, MD
Professor of Urology. Dr. Marks completed training at UCLA in 1978. H received an American Foundation for Urologic Diseases scholarship award and a Prostate Cancer Foundation research award. His current research interests involve prostate markers, imaging, and minimally-invasive treatments.
Allan J. Pantuck, MD
Professor of Urology and Vice Chair of Academic Affairs for Urology. Dr. Pantuck specializes in urologic cancers and has a long standing interest in kidney, prostate, bladder cancers, developing new treatment strategies through basic and clinical research and in the study of nutritional approaches to their prevention and treatment.
Robert E. Reiter, MD
Professor of Urology, Professor of Molecular Biology, Chief of the Division of Urologic Oncology, Director of the Prostate Cancer Program, Bing Research Chair in Urology, Co-Director of the Genitourinary Oncology Program in UCLA's Jonsson Cancer Center. Dr. Reiter attended Stanford Medical School, completed urologic training at Stanford and Baylor College of Medicine, completed additional fellowship training in urological cancer at the National Cancer Institute.
Nazy Zomorodian, NP
Adjunct Assistant Professor of Urology, Director of the Genitourinary Clinical Trials and Nurse Practitioner for the Department of Urology. She received her BS and Masters of Science in Nursing from the Hahnermann University in Philadelphia and is working on her PhD in Research Nursing at UCLA.